524.05
1.42%
7.36
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $524.05, with a volume of 2.42M.
It is up +1.42% in the last 24 hours and up +2.19% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
See More
Previous Close:
$516.69
Open:
$516.69
24h Volume:
2.42M
Relative Volume:
1.51
Market Cap:
$200.45B
Revenue:
$42.37B
Net Income/Loss:
$6.14B
P/E Ratio:
34.34
EPS:
15.26
Net Cash Flow:
$7.78B
1W Performance:
-0.54%
1M Performance:
+2.19%
6M Performance:
-5.95%
1Y Performance:
+0.89%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-14-24 | Initiated | Redburn Atlantic | Buy |
Oct-01-24 | Initiated | Stephens | Overweight |
Aug-28-24 | Initiated | Wells Fargo | Overweight |
Jun-03-24 | Resumed | Jefferies | Buy |
Mar-18-24 | Resumed | Citigroup | Neutral |
Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
Dec-18-23 | Initiated | HSBC Securities | Buy |
Dec-13-23 | Initiated | Wolfe Research | Outperform |
Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Sep-28-23 | Initiated | Bernstein | Outperform |
Sep-06-23 | Resumed | Citigroup | Buy |
Jul-19-23 | Initiated | Raymond James | Outperform |
Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
Apr-04-23 | Reiterated | Barclays | Overweight |
Dec-14-22 | Initiated | Deutsche Bank | Buy |
Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
Aug-25-22 | Initiated | Credit Suisse | Neutral |
Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Jan-26-22 | Resumed | Barclays | Overweight |
Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
Oct-15-21 | Resumed | Cowen | Outperform |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Jul-16-21 | Initiated | The Benchmark Company | Buy |
Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-03-21 | Initiated | Barclays | Overweight |
Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
Dec-02-20 | Initiated | Goldman | Buy |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-30-20 | Initiated | Atlantic Equities | Overweight |
Sep-14-20 | Initiated | Morgan Stanley | Overweight |
Aug-20-20 | Resumed | JP Morgan | Overweight |
Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
Jul-07-20 | Reiterated | Needham | Buy |
Apr-23-20 | Reiterated | Needham | Buy |
Jan-31-20 | Reiterated | Needham | Buy |
Jan-22-20 | Initiated | Credit Suisse | Neutral |
Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
Jan-07-20 | Initiated | Citigroup | Buy |
Nov-15-19 | Initiated | Stifel | Buy |
Jul-25-19 | Reiterated | Needham | Buy |
Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
May-30-19 | Initiated | Wolfe Research | Outperform |
May-23-19 | Reiterated | Needham | Strong Buy |
Apr-22-19 | Reiterated | Needham | Strong Buy |
Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Jim Cramer Reports That Thermo Fisher Scientific Inc. (TMO)’s China Sales Were Flat Year-Over-Year In The Nine Months Ending In September - Yahoo Finance
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by M&T Bank Corp - MarketBeat
Primary Cells Market Key Players AnalysisThermo Fisher - openPR
Allergy Diagnostic Market New Product Development & Latest Trends | Thermo Fisher Scientific, PerkinElmer, Danaher - openPR
Gamma Ray Spectroscopy Market Is Booming Worldwide 2024-2031 | - openPR
mRNA Extraction and Purification Market Top PlayersQiagen, - openPR
Focused Ion Beam Market to Set Phenomenal Growth From 2024 to 2032 | Thermo Fisher Scientific, Tescan, JEOL - openPR
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc. stock outperforms market despite losses on the day - MarketWatch
Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific - Business Wire
Thermo Fisher (TMO) Stock Is Ready For Breakout, Here’s Why - Insider Monkey
Thermo Fisher Scientific's SWOT analysis: stock outlook amid market shifts - Investing.com
Thermo Fisher Scientific Inc. stock falls Tuesday, still outperforms market - MarketWatch
Next Generation Sequencing Market Size, Share & Growth Forecast with CAGR 14.5% by 2031 | Thermo Fisher - EIN News
Research Antibodies Market to See Booming Growth 2024-2031 | - openPR
Clinical Oncology Next Generation Sequencing Market Top - openPR
Brain Cancer Diagnostics Market Top Companies StudyThermo - openPR
Plant Tissue Culture Market Detailed In New Research Report 2024 - openPR
Tumor Microenvironment Market Key Players AnalysisThermo - openPR
FCO clears Olink’s acquisition by Thermo Fisher following in-depth review - Cleary Antitrust Watch
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Scanfil Suzhou Factory Receives Sustainability Award from Thermo Fisher Scientific - I-Connect007
Single-Use Bioprocessing Market Projected to Surpass USD 100.9 Billion by 2032 with a 15.9% CAGR – SNS Insider - GlobeNewswire Inc.
Neglected Tropical Disease Treatment Market Key Players - openPR
Gene Panel Market CAGR of 20.2% Trends, Shares and Demand Analysis By 2024 To 2031 | Thermo Fisher Scientific - EIN News
The Zacks Analyst Blog Highlights Visa, Linde, Thermo Fisher Scientific, Tile Shop and Autoscope - Yahoo Finance
Leerink Partnrs Issues Pessimistic Forecast for TMO Earnings - MarketBeat
Thermo Fisher Scientific Says FDA Cleared Its Biomarkers for Pregnancy Complication - Marketscreener.com
1,032 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Bought by Virtu Financial LLC - MarketBeat
Lord Abbett & CO. LLC Sells 2,758 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) Price Target Cut to $660.00 by Analysts at Bank of America - MarketBeat
Thermo Fisher Scientific to Acquire CorEvitas For $912.5 Million in Cash - Marketscreener.com
Top Analyst Reports for Visa, Linde & Thermo Fisher Scientific - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Retirement Systems of Alabama Raises Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - GlobeNewswire Inc.
Oddo BHF Asset Management Sas Buys New Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Peapack Gladstone Financial Corp - MarketBeat
Franklin Resources Inc. Has $2.94 Billion Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Sunbelt Securities Inc. Cuts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Share Price Not Quite Adding Up - Simply Wall St
Thermo Fisher: The Cycle Has Already Turned Around - Seeking Alpha
Al in Omics Studies Market Top PlayersThermo Fisher - openPR
Syringe Filter Market Key Players AnalysisMerck Group, Thermo - openPR
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
Thermo Fisher Scientific Junior Innovators Challenge - WSBT-TV
Blankinship & Foster LLC Makes New Investment in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Arvest Bank Trust Division Makes New Investment in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Clinical Trial Supplies Global Market Forecast Report and Company Analysis 2025-2033, Profiles of Almac Group, Biocair, DHL, Thermo Fisher Scientific, Marken, Paraxel, Sharp Services, and PCI Pharma Services - AccessWire
Sanctuary Advisors LLC Boosts Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Chelsea Counsel Co. Trims Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):